Reuters logo
BRIEF-Viking Therapeutics Q4 loss per share $0.18
March 21, 2017 / 8:11 PM / 9 months ago

BRIEF-Viking Therapeutics Q4 loss per share $0.18

March 21 (Reuters) - Viking Therapeutics Inc

* Viking therapeutics reports fourth quarter and year-end 2016 financial results and provides corporate update

* Q4 loss per share $0.18

* Q4 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S

* Viking therapeutics inc - at december 31, 2016, viking held cash, cash equivalents and investments totaling $13.2 million.

* Says company currently expects to complete phase 2 trial of vk2809 in late 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below